Efficacy of Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses in Healthy Subjects
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy Volunteers
- Sponsor
- University of Las Palmas de Gran Canaria
- Enrollment
- 15
- Primary Endpoint
- Response speed of the central and peripheral nervous system to a stimulus 1
- Status
- Not yet recruiting
- Last Updated
- 8 months ago
Overview
Brief Summary
Somatosensory evoked potentials are crucial in determining the physiological changes of potentials in nerve pathways. Although their main function is diagnostic, the investigators have recently been used as a physiological test to determine physioelectric changes in healthy subjects to study applied stimuli, such as laser, pain or electrotherapy.
Detailed Description
The general configuration of the study consists of a study before and after the block of sessions to be determined, and differences of all the variables measured before and after NESA therapy will be compared through the mechanisms of somatosensory evocations. Given its potential use, the objective of this study is to determine if there are changes in the somatosensory evoked potentials of the ulnar, median, tibial, peroneal and vagus nerves when non-invasive neuromodulation NESA is applied, which is used as a physiotherapy treatment. for objectives such as pain, vegetative affectations and sleep disorders. The variables of the study will be collected at two time points: before the intervention and at the end of the intervention. The statistical analysis will be an intention-to-treat analysis. For the main outcomes variables a two factor ANOVA will-be performed (intervention-time) with a post-hoc analysis with kruskal wallis correction correction. Statistical significance will be defined as p \<0.05
Investigators
Aníbal Báez Suárez
Principal Investigator
University of Las Palmas de Gran Canaria
Eligibility Criteria
Inclusion Criteria
- •Healthy people
- •Optimal cognitive abilities and mentally competent to participate in the study.
- •In condition to complete the study questionnaires.
Exclusion Criteria
- •Focal mononeuropathies in both upper and lower limbs
- •Peripheral neuropathy.
- •Patients with implanted functioning pacemakers / defibrillators. Patients with bleeding disorders. Patients being treated with anticoagulants. Patients on antiplatelet therapy.
- •Present some of the contraindications for a treatment with NESA XSIGNAL®: pacemakers, internal bleeding, do not apply electrodes on skin in bad condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and / or electricity phobia.
- •Not having signed the informed consent.
- •Present any injury or pathology during the study
Outcomes
Primary Outcomes
Response speed of the central and peripheral nervous system to a stimulus 1
Time Frame: Up to 1 month
The Somatosensory Evoked Potentials of both median and ulnar nerves will be evaluated. Neurophysiological tests of the nervous system that functionally assesses the nerve pathways of the central and peripheral nervous system. For its evaluation, distal stimuli are generated in the wrists in the range of 3-4Hz with intensities above the sensitive threshold and below the pain threshold.
Secondary Outcomes
- Response speed of the central and peripheral nervous system to a stimulus 2(Up to 1 month)
- Response speed of the central and peripheral nervous system to a stimulus 3(Up to 1 month)
- Response speed to sensitive stimuli in the palms of the hand and sole of the feet(Up to 1 month)